A study for a 49 year old woman who takes Gleevec - from FDA reports

1,814 females aged 49 (±5) who take the same drug are studied. This is a personalized study for a 49 year old female patient who has Chronic Myelogenous Leukemia (Cml). The study is created by eHealthMe based on reports from FDA.

On Jun, 13, 2018

1,814 females aged 49 (±5) who take Gleevec are studied.

Number of reports submitted per year:

Gleevec for a 49-year old woman.

Information of the patient in this study:

  • Age: 49
  • Gender: female
  • Conditions: Chronic Myelogenous Leukemia (Cml)
  • Drugs taken:
    • Gleevec (imatinib mesylate)

eHealthMe real world results:

Most common side effects over time

< 1 month:
  1. Rashes (redness)
  2. Nausea (feeling of having an urge to vomit)
  3. White blood cell count decreased
  4. Breathing difficulty
  5. Headache (pain in head)
1 - 6 months:
  1. Fatigue (feeling of tiredness)
  2. Malignant neoplasm progression (cancer tumour came back)
  3. Thrombocytopenia (decrease of platelets in blood)
  4. Rashes (redness)
  5. Nausea and vomiting
6 - 12 months:
  1. Rashes (redness)
  2. Fever
  3. Thrombocytopenia (decrease of platelets in blood)
  4. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  5. Oedema peripheral (superficial swelling)
1 - 2 years:
  1. Fatigue (feeling of tiredness)
  2. Nausea and vomiting
  3. Thrombocytopenia (decrease of platelets in blood)
  4. Haemoglobin decreased
  5. Fever
2 - 5 years:
  1. Nausea (feeling of having an urge to vomit)
  2. Diarrhea
  3. Gastrointestinal stromal tumor
  4. Malignant neoplasm progression (cancer tumour came back)
  5. Nausea and vomiting
5 - 10 years:
  1. White blood cell count increased
  2. Fever
  3. Heart attack
  4. Chest pain
  5. Malignant neoplasm progression (cancer tumour came back)
10+ years:
  1. Diarrhea
  2. Bone density decreased
  3. Oral pain
  4. Rashes (redness)
  5. Mesenteric artery thrombosis (blood clot in mesenteric artery)
not specified:
  1. Death
  2. Nausea (feeling of having an urge to vomit)
  3. Diarrhea
  4. Rashes (redness)
  5. Fatigue (feeling of tiredness)

Top conditions involved for these people *:

  1. Gastrointestinal Stromal Tumor : 210 people, 11.58%
  2. Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 83 people, 4.58%
  3. Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 29 people, 1.60%
  4. Depression : 28 people, 1.54%
  5. Neoplasm Malignant (cancer tumour): 28 people, 1.54%

Top co-used drugs for these people *:

  1. Tasigna (45 people, 2.48%)
  2. Methotrexate (36 people, 1.98%)
  3. Allopurinol (32 people, 1.76%)
  4. Lasix (32 people, 1.76%)
  5. Dasatinib (26 people, 1.43%)

* Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Want to find out more about the FDA reports used in the study? You can request them from FDA.

You are not alone: Connect with people like you, or share your experience to help people like you.

What are the drugs?

What are the conditions?

Related studies:

Related publications that referenced our studies

You may be interested in these posts

More posts for: Gleevec, Chronic myelogenous leukemia (cml)

Related tests

We suggest these affordable tests for self monitoring. You can order them and receive results on eHealthMe. No doctor referral or insurance necessary.

NOTE: The study is based on active ingredients. Other drugs that have the same active ingredients are also considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.